Silexion Therapeutics Current Assets

Silexion Therapeutics (SLXN) currently reports a current assets of $4.1M as of March 2026. That compares with $7.7M in the prior-year period — down 47.4% year over year. Use the charts on this page to explore Silexion Therapeutics's current assets history and peer comparisons.

Silexion Therapeutics's current assets decreased from $7.7M to $4.1M — a 47.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Silexion Therapeutics reported $4.1M in current assets as of March 2026. That compares with $7.7M in the prior-year period — down 47.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $4.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Silexion Therapeutics, and consider following SLXN for alerts when major investors trade the stock.